Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Challenges and successes in developing new therapies for hepatitis C
2005 Nature
Strong and Reversible Binding of Carbon Dioxide in a Green Metal–Organic Framework
2011 StandoutNobel
Asymmetric Counteranion‐Directed Catalysis: Concept, Definition, and Applications
2012 StandoutNobel
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Asymmetric Counteranion‐Directed Transition‐Metal Catalysis: Enantioselective Epoxidation of Alkenes with Manganese(III) Salen Phosphate Complexes
2009 StandoutNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Treatment triumphs
2014 StandoutNatureNobel
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
2013
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Carbon–heteroatom bond formation catalysed by organometallic complexes
2008 StandoutNature
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
The role of resistance in HCV treatment
2012
The Lipid Kinase Phosphatidylinositol-4 Kinase III Alpha Regulates the Phosphorylation Status of Hepatitis C Virus NS5A
2013
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014
Metazoan MicroRNAs
2018 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Antiviral strategies in hepatitis C virus infection
2012
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Insights into hRPA32 C-terminal domain–mediated assembly of the simian virus 40 replisome
2005
Peptiderive server: derive peptide inhibitors from protein–protein interactions
2016
Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
2014
Hepatitis C Virus Entry
2007 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Modulating the Binding of Polycyclic Aromatic Hydrocarbons Inside a Hexacationic Cage by Anion–π Interactions
2014 StandoutNobel
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Pd‐Catalyzed Stereoselective Oxidation of Methyl Groups by Inexpensive Oxidants under Mild Conditions: A Dual Role for Carboxylic Anhydrides in Catalytic CH Bond Oxidation
2005
Palladium‐Catalyzed Asymmetric Iodination of Unactivated CH Bonds under Mild Conditions
2005
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014
An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair
2009 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Mapping of Protein-Protein Interactions: Web-Based Resources for Revealing Interactomes
2018
Phosphoinositides in the Hepatitis C Virus Life Cycle
2012
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
The selective functionalization of saturated hydrocarbons: Gif chemistry
1992
Pillar[5]arene as a Co-Factor in Templating Rotaxane Formation
2013 StandoutNobel
C-H Bond Functionalization in Complex Organic Synthesis
2006 StandoutScience
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
Engineering enzymes for noncanonical amino acid synthesis
2018 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method To Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes from HCV Genotypes 1 to 6
2010
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Self-Assembled Nanoreactors
2005
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Biomimetic Chemistry and Artificial Enzymes: Catalysis by Design
1995
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Chromium− and Manganese−salen Promoted Epoxidation of Alkenes
2005
Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts
2015 StandoutNobel
Unusual Amino Acids in Medicinal Chemistry
2016
Catalytic Asymmetric Epoxidation of α-Branched Enals
2010 StandoutNobel
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Model systems for cytochrome P450 dependent mono-oxygenases. Part 7. Alkene epoxidation by iodosylbenzene catalysed by ionic iron(III) tetraarylporphyrins supported on ion-exchange resins
1990
Electrochemical synthesis of 1-N-phenyl-4-(sulfonyl)benzene-1,2-diamine derivatives: a mild and regioselective protocol
2016
Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
2011
Palladium-Catalyzed Ligand-Directed C−H Functionalization Reactions
2010 Standout
Flaviviridae Replication Organelles: Oh, What a Tangled Web We Weave
2015
The Catalytic Valorization of Lignin for the Production of Renewable Chemicals
2010 Standout
Works of Peter W. White being referenced
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
2010
Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3–NS4A proteins
2009
Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor
2004
Discovery of the first series of inhibitors of human papillomavirus type 11: inhibition of the assembly of the E1–E2–Origin DNA complex
2003
Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1–E2 protein–protein interaction: A combined medicinal chemistry, NMR and computational chemistry approach
2007
Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction
2003
In Vitro Resistance Profile of the Hepatitis C Virus NS3 Protease Inhibitor BI 201335
2011
Sensitivity of NS3 Serine Proteases from Hepatitis C Virus Genotypes 2 and 3 to the Inhibitor BILN 2061
2004
Characterization of the DNA-Binding Properties of the Origin-Binding Domain of Simian Virus 40 Large T Antigen by Fluorescence Anisotropy
2003
758 CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO BY THE HCV NS3/4A PROTEASE INHIBITOR BI 201335
2010
Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution
2013
Substrate selectivity in epoxidation by metalloporphyrin and metallosalen catalysts carrying binding groups
1989
Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease
2010
Mechanistic studies and selective catalysis with cytochrome P-450 model systems
1990
Evaluation of Phosphatidylinositol-4-Kinase IIIα as a Hepatitis C Virus Drug Target
2012
Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)
2010
Discovery of Small-Molecule Inhibitors of the ATPase Activity of Human Papillomavirus E1 Helicase
2003